inflammatory bowel disease

In inflammatory bowel disease, the experimental models have been proven to be important tools to investigate the potential therapeutic agent and to study the mechanism of pathogenesis.

实验动物模型对于发现抗炎症性肠病的药物及探讨其发病机制具有重要作用。

Early diagnosis and treatment is important for the patients with osteoporosis in inflammatory bowel disease.

对于炎症性肠病患者并发骨质疏松者应及早诊断及治疗,早期干预可减轻IBD患者骨质疏松的发生与发展.

Nanjing medical university hospital affiliated suzhou ZhengGuJu professor report "inflammatory bowel disease epidemiology and Chinese research situation".

南京医科大学附属苏州医院郑家驹教授报告《炎症性肠病的流行病学及中国研究概况》。

Azathioprine ( AZA) and 6-mercaptopurine ( 6-MP) have a well-established effect as an immunosuppressive agent for inflammatory bowel disease ( IBD), Myelosuppression is the most serious side effect during treatment.

硫唑嘌呤（AZA）/6-巯嘌呤（6-MP）是治疗炎性肠病（IBD）的重要药物，治疗过程中最严重的不良反应是骨髓抑制。

CONCLUSION: NF-κ B decoy ODNs will become a new gene drug for treating inflammatory bowel disease ( IBD ) .

结论: NF - κ BdecoyODNs 有望成为治疗IBD的一种新型基因药品.

Animal models inflammatory bowel disease can be induced by chemical, immunology, genetics and other access methods.

炎症性肠病动物模型可通过化学性诱导 、 免疫学 、 遗传学等方法获得.

Objective : To improve the therapeutic effect of inflammatory bowel disease ( IBD ).

目的: 进一步提高炎症性肠病的治疗效果.

Chronic diarrhea is usually related to functional disorders such as bowel syndrome or inflammatory bowel disease.

而慢性腹泻往往和相应的肠胃功能紊乱有关,例如肠易激综合征或炎症性肠病.

Osteoporosis in patients with inflammatory bowel disease: risk factors, prevention, and treatment.

骨质疏松症的炎症性肠病患者: 危险因素, 预防和治疗.